Genprex Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-30.86	-23.74	-20.66	-17.94	-10.65	-12.37	-3.31	-4.13	-1.07
Depreciation & Amortization	0.02	0.03	0.02	0.02	0.01	0.01	0	0	0
Share-Based Compensation	5.41	4.73	5.35	4.25	3.53	5.44	1.32	2.66	0.44
Other Operating Activities	0.7	1.36	1.01	-0.26	0.19	0.08	-0.18	0.23	-0.06
Operating Cash Flow	-24.74	-17.62	-14.28	-13.94	-6.92	-6.85	-2.17	-1.25	-0.69
Capital Expenditures	0	0	-0.03	-2.23	-0.84	-0.02	-0.01	-0	-0
Other Investing Activities	-0.07	-0.06	-0.05	-0.11	-0.11	-0.08	-0.06	-0.08	-0.02
Investing Cash Flow	-0.07	-0.06	-0.08	-2.34	-0.95	-0.1	-0.06	-0.09	-0.02
Share Issuance / Repurchase	10.59	0.01	25.68	41.59	1.27	15.39	0.79	2.71	0.2
Other Financing Activities	-	-	-	-	-	-	-	-	0.52
Financing Cash Flow	10.59	0.01	25.68	41.59	1.27	15.39	0.79	2.71	0.72
Net Cash Flow	-14.22	-17.67	11.31	25.32	-6.6	8.44	-1.44	1.37	0.02
Free Cash Flow	-24.74	-17.62	-14.32	-16.16	-7.75	-6.87	-2.18	-1.25	-0.69
Free Cash Flow Per Share	-18.09	-14.70	-12.16	-18.20	-19.35	-19.95	-7.57	-4.63	-14.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).